Healthcare Procurement of Clinical Commissioning Groups in the UK：Experience and Implications

doi:10.12114/j.issn.1007-9572.2021.00.203

Abstract

Abstract: Strategic procurement is a key way to improve the utilization efficiency of health insurance fund. The financing of England is not the bismarck model，but Clinical Commissioning Groups（CCGs） still can provide some experience for strategic procurement in China. The promotion of primary healthcare is important to achieve "healthcare for all". General practitioners being involved and responsible for CCGs enable purchasers to have a good understanding of residents' healthcare needs，so that they can communicate with suppliers more effectively，which is the essential premise of implementing strategic procurement. CCGs are formed by general practice clinics spontaneously using a bottom-up approach，which are totally built on the special local situation with differences by scale and governing structure，aiming to help to satisfy residents' healthcare needs，ensure continuous improvement of service quality，reduce healthcare inequality，ensure the right for choosing healthcare and patient participation，promote the provision of integrated health services and reduce the use of inpatient services.

Key words: Clinical commissioning groups, Integrated care, Strategic purchasing

摘要： 战略性购买是我国提高医保资金利用效率的关键举措。英国卫生筹资制度虽然不是社会医疗保险模式，但其卫生服务购买组织——临床委托服务组织（CCGs）为我国实施战略性购买提供了一些有益的经验。推行初级卫生保健是实现“人人享有卫生保健”的关键和基本途径。全科医生加入并领导CCGs使得采购组织能够直接了解患者需求，而且有能力跟卫生服务提供方对话，这是实施战略性购买的基本前提。另外，CCGs是自下而上由全科诊所自发形成的，有不同的规模和治理结构，完全基于各地的实际需要并有助于满足群众的需要，有利于确保服务质量的持续改进、减少不公平、保障选择权和患者参与，并促进整合型卫生服务的提供，减少住院服务利用，提高资金利用效率。

关键词: 临床委托服务组织, 整合型服务, 战略购买

ZHANG Xiaojuan,ZHU Kun. Healthcare Procurement of Clinical Commissioning Groups in the UK：Experience and Implications　[J]. Chinese General Practice, 2021, 24(22): 2757-2764. DOI: 10.12114/j.issn.1007-9572.2021.00.203.
张小娟,朱坤. 英国卫生服务购买经验及启示[J]. 中国全科医学, 2021, 24(22): 2757-2764. DOI: 10.12114/j.issn.1007-9572.2021.00.203.

References

［1］Health Committee. Commissioning：fourth report of session 2009—2010 ［R］. London：House of Commons，2010.
［2］MAYS N，DIXON A，JONES L. Understanding new labour's market reforms of the English NHS ［R］. London：the King's Fund，2011.
［3］SMITH J，CURRY N，MAYS N，et al. Where next for commissioning in the English NHS?［R］ . London：Nuffield Trust，2010.
［4］MCDERMOTT I，COLEMAN A，PERKINS N，et al. Exploring the GP' added value' in commissioning：what works，in what circumstances，and how'?［R］. PRU Comm：University of Manchester，2015.
［5］MILLER R，PECKHAM S，COLEMAN A，et al. What happens when GPs engage in commissioning? Two decades of experience in the English NHS［J］. Journal of Health Services Research and Policy，2015，21（2）：126-133. DOI：10.1177/1355819615594825.
［6］Secretary of State for Health. Government response to the NHS future forum report［R］. London：Department of Health，2011.
［7］Department of Health. Equity and excellence：liberating the NHS［R］. London：the Stationary Office，2010.
［8］NHS England，Care Quality Commission，NHS Health Education England，et al. The NHS five year forward view［R］. London：National Audit Office，2014.
［9］NHS England. A review of the role and costs of clinical commissioning groups［R］. London：National Audit Office，2018.
［10］NAYLOR C，CURRY N，HOLDER H，et al. Clinical commissioning groups Supporting improvement in general practice? ［R］. London：the King's Fund Nuffield Trust，2013.
［11］NHS England. CCGS improvement and assessment framework 2016/17［R］. London：NHS England，2016.
［12］IMISON C，ASHTON B，STEWARD K，et al. Good governance for clinical commissioning groups：an introductory guide［R］. London：the King's Fund，2011.
［13］DEPANI N. Practical guide to engaging with clinical commissioning groups［R］. London：Compact Voice，2015.
［14］Department of Health and Social Care. Department of health and social care annual report and accounts 2018—2019 ［R］. London：Department of Health and Social Care，2019.
［15］MCDERMOTT I，CHECKLAND K，WARWICK-GILES L，et al. Understanding primary care co-commissioning：uptake，scope of activity and process of change. Interim report ［R］. Manchester：Policy Research Unit in Commissioning and the Healthcare System，2016.
［16］MCDERMOTT I，CHECKLAND K，COLEMAN A. Primary care co-commissioning：challenges faced by clinical commissioning groups in England［J］. Br J Gen Pract，2018，68（666）：37-38. DOI：10.3399/bjgp17X694325.
［17］ROBERTSON R，HOLDER H，ROSS S，et al. Clinical commissioning：GPs in charge? ［R］. London：the King's Fund and Nuffield Trust，2016.
［18］NHS England. Clinical commissioning groups（CCGSs） with delegated and joint arrangements as of 1 April 2018［R］. London：NHS England，2018.
［19］GRUNDMEIJER H. General practitioner and specialist：why do they communicate so badly?［J］. Eur J Gen Pract，2009，2：53-54. DOI：10.3109/13814789609162141.
［20］VALENTIJN P P，SCHEPMAN S M，OPHEIJ W，et al. Understanding integrated care：a comprehensive conceptual framework based on the integrative functions of primary care［J］. Int J Integr Care，2013，13：e010. DOI：10.5334/ijic.886.
［21］CALNAN M，HUTTEN J，TILJAK H. The challenges of coordination：the role of primary care professionals in promoting integration across the interface［M］//SALTMAN R B，RICO A，BOERMA W，et al. Primary care in the driver's seat? Organisational reform in European primary care. Berkshire，England：Open University Press，2006：85-104.
［22］HAM C，ALDERWICK H. Place-based systems of care：a way forward for the NHS in England［R］. London：The King's Fund，2015.
［23］RACHAEL H. NHS Funding Allocations：Clinical Commissioning Groups［Z］. 2019.
［24］HOLDER H，ROBERTSON R，ROSS S，et al. Risk or reward? The changing role of CCGs in general practice［R］. London：the Nuffield Trust，2015.
［25］BAIRD B，CHARLES A，HONEYMAN M，et al. Understanding pressures in general practice［R］. London：the King's Fund，2016.
［26］IACOBUCCI G. BMJ investigation finds GP conflicts of interest "rife" on commissioning boards［R］. London：British Medical Journal Website，2013.
［27］JENSEN M C，MECKLING W H. Theory of the firm：managerial behavior，agency costs and ownership structure［J］. J Financ Econ，1976，3：305-360. DOI：10.1016/0304-405X(76)90026-X.
［28］SMITH P C，STREET A，SMITH P C，et al. Concepts and challenges in measuring the performance of health care organizations［M］//JONES A. The elgar companion to health economics. Cheltenham：Edward Elgar，2012：341-349.
［29］HART O. Corporate governance：some theory and implications［J］. Economic Journal，1995，105（430）：678-689. DOI：10.2307/2235027.
［30］INGLEY C B，VAN DER WALT N T. Corporate governance，institutional investors and conflicts of interest［J］. Corporate Governance，2004，12（4）：534-551. DOI：10.1111/j.1467-8683.2004.00392.x.
［31］REHBEIN K. What does more executive discretion mean for corporate governance?［J］. Acad Manag Perspect，2009，23（2）：101-103. DOI：10.5465/amp.2009.39985547.
［32］NHS Clinical Commissioners. Making strategic commissioning work：lessons from home and away［R］. London：NHS Confederation，2017.
［33］SIMON J. The changing commissioning landscape［R］. London：NHS Clinical Commissioners，2017.
［34］KLASA K，GREER S L，VAN GINNEKEN E. Strategic purchasing in practice：comparing ten European countries［J］. Health Policy，2018，122（5）：457-472. DOI：10.1016/j.healthpol.2018.01.014.

[1]	YANG Hui. Cooperated and Shared Care: Reflections on Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(22): 2711-2714.
[2]	DENG Hongyu, WU Miaomiao, YANG Zheng, HE Yang, ZHU Linlin, ZHAO Qian, DAI Hua, WU Jia, LIAO Xiaoyang, ZHANG Yonggang. Construction of an Innovative Model of Chronic Disease Management in Compact County Medical Alliance with Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(22): 2720-2725.
[3]	PEI Linxi，WEI Xinping. A Brief Summary of the 22nd WONCA World Conference of Family Doctors　#br# [J]. Chinese General Practice, 2019, 22(4): 383-386.